Study explores whole-body immunity

November 21, 2017 by Peter Reuell, Harvard University
Credit: CC0 Public Domain

Over the next few months, millions of people will receive vaccinations in the hope of staving off the flu—and the fever, pain, and congestion that come with it.

But how can one injection trigger an that protects someone from head to toe?

Part of the answer, says Nicolas Chevrier, a former Bauer Fellow at the Harvard FAS Center for Systems Biology and now an assistant professor in molecular engineering at the University of Chicago, appears to lie in the way antiviral signals spread through the body within hours of a vaccination, seeding in various tissues. Chevrier's findings are described in an Oct. 5 paper published in Cell.

"The starting point for this study was the question of how do we study the at the scale of the whole organism?" Chevrier said. "Immune cells are in every organ of the body—in the lungs, the heart, the skin—making it incredibly challenging to study how the immune system can operate across the entire organism. Current studies are siloed. For example, people only looked at the lungs or only looked at the blood."

To find answers, Chevrier and colleagues turned to a pair of Vaccinia viruses—one a pathogenic version of the disease and the other an inactive strain deployed for formulating vaccines similar to those used to eradicate smallpox in the early 20th century.

"To test our idea, we wanted something to trigger and compare various types of immune responses from vaccination alone, to infection alone, and to a protective one [infection of vaccinated individuals]," he said. "Using this comparative approach allowed us to ask: When you immunize at the skin, does the response stay localized, or does it become systemic? And if so, how far and how fast does it spread? These are fundamental questions about the inner working of the immune system at a scale that we didn't have any way to look at."

Researchers first immunized mice against the disease to study how their immune systems responded to the vaccine, and later exposed the same mice to the pathogenic version of the virus to study how it triggered their immune defenses.

"We were very excited to see that our approach worked," Chevrier said. "We could observe and track immune processes at the whole-body scale for the first time. Based on these findings, we uncovered two new mechanisms of critical for the host. First, we found that within hours of being vaccinated, a whole-body antiviral is created—as if the body's defenses were anticipating its virus opponent's next moves to win the battle."

That process, he explained, involves a molecule known as interferon, which is secreted at the point of immunization, and quickly propagates through most tissues via the bloodstream.

For years, Chevrier said, scientists believed interferon was merely a local response to an immune trigger, but the new study suggests that it may actually play an important role in activating antiviral genes across many tissues, helping them fight off infection.

What Chevrier dubbed the protective response, on the contrary, seems far more localized to a few organs.

"It seems to be more restrained to where the virus goes," he said. "In our tests, the infection came in through the lungs, and very quickly progressed to the liver and the spleen. But the immune defenses set by vaccination stopped the virus right there, and very efficiently. We found that memory cells are instructed to reside in those tissues and are set up to counter a potential reinfection."

That finding contradicts accepted wisdom, which had been that those cells could most effectively fight infection by circulating through the body. In recent years, however, evidence has emerged suggesting that the resident cells might be more potent and widespread than first thought.

"They were seen as local protectors," Chevrier said. "People thought that when you got immunized at the skin, for example, those cells would reside in the skin, but what we've found is that they're seeded much more broadly across the body to serve as systemic protectors. So as soon as the virus arrives in the liver or the spleen, those are ideally placed to fight off the infection as it unfolds."

He added: "Our study is a proof of principle that the immune system can be observed and studied at the whole-body scale in mammals—as opposed to one or few tissues at a time. That being said, much effort is now needed to test this idea in other immune processes linked to health and disease."

Explore further: Zika-related nerve damage caused by immune response to the virus

More information: Motohiko Kadoki et al. Organism-Level Analysis of Vaccination Reveals Networks of Protection across Tissues, Cell (2017). DOI: 10.1016/j.cell.2017.08.024

Related Stories

Zika-related nerve damage caused by immune response to the virus

November 20, 2017
The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients ...

New knowledge on how HIV beats the body's early immune response

September 14, 2017
In an important step towards eradicating HIV-associated viral reservoirs, researchers at Sydney's Westmead Institute for Medical Research have identified how the HIV virus hijacks the innate immune system to facilitate its ...

Scientists find potential mechanism for deadly, sepsis-induced secondary infection

September 14, 2017
In mice, an infection-induced condition known as sepsis may increase the risk of life-threatening secondary infection by preventing recruitment of infection-fighting cells to the skin, according to new research published ...

Blood-filtering organs fight infections that enter through the skin

August 16, 2017
New information about how and where the innate immune system fights off viral infections that enter through the skin could lead to better treatments for viruses like Zika, dengue and measles, according to Penn State College ...

Mouse model could shed new light on immune system response to Zika virus

February 23, 2017
A new mouse model with a working immune system could be used in laboratory research to improve understanding of Zika virus infection and aid development of new treatments, according to a study published in PLOS Pathogens.

Recommended for you

New findings suggest allergic responses may protect against skin cancer

July 17, 2018
The components of the immune system that trigger allergic reactions may also help protect the skin against cancer, suggest new findings.

The immune system: T cells are built for speed

July 17, 2018
Without T cells, we could not survive. They are a key component of the immune system and have highly sensitive receptors on their surface that can detect pathogens. The exact way that these receptors are distributed over ...

Broadly acting antibodies found in plasma of Ebola survivors

July 17, 2018
Recent Ebola virus disease (EVD) outbreaks, including the 2013-2016 epidemic that ravaged West Africa and the 2018 outbreak in the Democratic Republic of the Congo, highlight the need for licensed treatments for this often-deadly ...

How protein fragments could help to tackle the cause of hay fever

July 16, 2018
Imperial researchers are looking to protein fragments to help people build up resistance to grass pollen.

Team explores diabetes drug's ability to treat RSV infection

July 13, 2018
A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs' small airways. A multi-disciplinary team of Vanderbilt investigators ...

Testing suggests TORC1 inhibitors can boost immune system in the elderly

July 12, 2018
A team of researchers affiliated with Novartis Institutes for Biomedical Research and Biometrics Matters Limited, has found via testing with volunteers that TORC1 inhibitors can boost the immune system in the elderly. In ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.